We found that silencing of PGC1α enhanced the efficacy of alisertib to reduce the cellular viability of the indicated GBM cells (Fig. 4o), suggesting that PGC1α acted as a pro-survival factor in the context of Aurora kinase A inhibition. Here, PPARGC1A is linked to glioblastoma.